From Surf Wiki (app.surf) — the open knowledge base
TRX2
Dietary supplement by Oxford BioLabs
Dietary supplement by Oxford BioLabs
| Field | Value |
|---|---|
| title | TRX2 |
| launch year | 2011 |
| company | Oxford BioLabs |
| available | Available |
| notes | Dietary supplement |
| url |
TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom, marketed in 2011.
Etymology and Formulation
The name TRX2 is said to be derived from the Ancient Greek word trichos, meaning hair and the number 2 stands for second generation. The proper word for hair in Ancient Greek is however thrix (θρίξ).
TRX2 contains amino acids and vitamins. Its ingredients are L-carnitine, L-tartaric acid, potassium chloride, L-leucine, isoleucine, valine, nicotinic acid, and biotin.
The product is a dietary supplement, not a drug, and hence it does not need approval by the U.S. Food and Drug Administration (FDA).
Oxford BioLabs
Oxford BioLabs was founded in August 2008 as a Limited Liability Company in England and Wales by former scientists of the University of Oxford, including biochemist and entrepreneur Thomas Whitfield. The company have German based Research Facilities located in Biopark Regensburg, Regensburg, Germany. According to an article published by The Daily Telegraph the company is bootstrapped by its founders as well as by NESTA and the National Council for Graduate Entrepreneurship (NCGE).
Clinical Studies
TRX2 has been tested by Oxford Biolabs in a clinical study.{{cite web|title=TRX2® HAIR SUPPLEMENT CLINICAL STUDY
The results of the study showed that 26 (out of a total 29) participants who had taken TRX2 recorded an increase of at least 10% in the number of hair strands in the evaluation area and/or a 10% increase in hair weight.
The third-party studies took place in 2019 and were conducted by the European Research Institute Dermatest.
Controversy
In January 2014 the UK Advertising Standards Authority upheld a complaint against TRX2 and Oxford Biolabs, citing that advertisements that the company had run for TRX2 were misleading and in breach of EU advertising codes. The company agreed and changed their advertising in line with the code of conduct.
References
References
- Tyler, Richard. (9 January 2011). "Thomas Whitfield's German roots help hair loss product launch". The Daily Telegraph.
- Tyler, Richard. (16 January 2009). "Thomas Whitfield: The Oxford student who plans to make baldness a thing of the past". The Daily Telegraph.
- "Oxford BioLabs". Oxford BioLabs.
- Liddell, H.G. & Scott, R. (1940). ''A Greek-English Lexicon. revised and augmented throughout by Sir Henry Stuart Jones. with the assistance of. Roderick McKenzie.'' Oxford: Clarendon Press.
- "Carnipure". Lonza.
- Edwards, Jim. (12 January 2011). "Pharma's 4 Best Shots at a Cure for Baldness". CBSNews.com.
- "Minoxidil Alternatives". MPB Research.
- (10 January 2011). "Thomas Whitfield's German roots help hair loss product launch". NCEE.
- "ASA Adjudication on Oxford Biolabs Ltd". Advertising Standards Authority.
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about TRX2 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report